A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)
Clinical trial NCT00827918 · COMPLETED
Trial details
- NCT number
- NCT00827918
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-04-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.